Copyright Reports & Markets. All rights reserved.

Global Biological Drugs Sales Market Report 2021

Request for Sample of this report
Buy now

1 Biological Drugs Market Overview

  • 1.1 Biological Drugs Product Scope
  • 1.2 Biological Drugs Segment by Type
    • 1.2.1 Global Biological Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Therapeutic Protein
    • 1.2.3 Monoclonal Antibody
    • 1.2.4 Vaccine
    • 1.2.5 Others
  • 1.3 Biological Drugs Segment by Application
    • 1.3.1 Global Biological Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Others
  • 1.4 Biological Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Biological Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Biological Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Biological Drugs Price Trends (2016-2027)

2 Biological Drugs Estimates and Forecasts by Region

  • 2.1 Global Biological Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Biological Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Biological Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Biological Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Biological Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Biological Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Biological Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Biological Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Biological Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Biological Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Biological Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Biological Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Biological Drugs Estimates and Projections (2016-2027)

3 Global Biological Drugs Competition Landscape by Players

  • 3.1 Global Top Biological Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Biological Drugs Players by Revenue (2016-2021)
  • 3.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2020)
  • 3.4 Global Biological Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Biological Drugs Market Size by Type

  • 4.1 Global Biological Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Biological Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Biological Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Biological Drugs Price by Type (2016-2021)
  • 4.2 Global Biological Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Biological Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Biological Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Biological Drugs Price Forecast by Type (2022-2027)

5 Global Biological Drugs Market Size by Application

  • 5.1 Global Biological Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Biological Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Biological Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Biological Drugs Price by Application (2016-2021)
  • 5.2 Global Biological Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Biological Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Biological Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Biological Drugs Price Forecast by Application (2022-2027)

6 North America Biological Drugs Market Facts & Figures

  • 6.1 North America Biological Drugs Sales by Company
    • 6.1.1 North America Biological Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Biological Drugs Revenue by Company (2016-2021)
  • 6.2 North America Biological Drugs Sales Breakdown by Type
    • 6.2.1 North America Biological Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Biological Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Biological Drugs Sales Breakdown by Application
    • 6.3.1 North America Biological Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Biological Drugs Sales Breakdown by Application (2022-2027)

7 Europe Biological Drugs Market Facts & Figures

  • 7.1 Europe Biological Drugs Sales by Company
    • 7.1.1 Europe Biological Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Biological Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Biological Drugs Sales Breakdown by Type
    • 7.2.1 Europe Biological Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Biological Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Biological Drugs Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Biological Drugs Market Facts & Figures

  • 8.1 China Biological Drugs Sales by Company
    • 8.1.1 China Biological Drugs Sales by Company (2016-2021)
    • 8.1.2 China Biological Drugs Revenue by Company (2016-2021)
  • 8.2 China Biological Drugs Sales Breakdown by Type
    • 8.2.1 China Biological Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Biological Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Biological Drugs Sales Breakdown by Application
    • 8.3.1 China 153 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Biological Drugs Market Facts & Figures

  • 9.1 Japan Biological Drugs Sales by Company
    • 9.1.1 Japan Biological Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Biological Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Biological Drugs Sales Breakdown by Type
    • 9.2.1 Japan Biological Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Biological Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Biological Drugs Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Biological Drugs Market Facts & Figures

  • 10.1 Southeast Asia Biological Drugs Sales by Company
    • 10.1.1 Southeast Asia Biological Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Biological Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Biological Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Biological Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Biological Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Biological Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Biological Drugs Market Facts & Figures

  • 11.1 India Biological Drugs Sales by Company
    • 11.1.1 India Biological Drugs Sales by Company (2016-2021)
    • 11.1.2 India Biological Drugs Revenue by Company (2016-2021)
  • 11.2 India Biological Drugs Sales Breakdown by Type
    • 11.2.1 India Biological Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Biological Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Biological Drugs Sales Breakdown by Application
    • 11.3.1 India Biological Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Biological Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Biological Drugs Business

  • 12.1 Bristol-Myers Squibb
    • 12.1.1 Bristol-Myers Squibb Corporation Information
    • 12.1.2 Bristol-Myers Squibb Business Overview
    • 12.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
    • 12.1.5 Bristol-Myers Squibb Recent Development
  • 12.2 Eli Lilly
    • 12.2.1 Eli Lilly Corporation Information
    • 12.2.2 Eli Lilly Business Overview
    • 12.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Eli Lilly Biological Drugs Products Offered
    • 12.2.5 Eli Lilly Recent Development
  • 12.3 Takeda
    • 12.3.1 Takeda Corporation Information
    • 12.3.2 Takeda Business Overview
    • 12.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Takeda Biological Drugs Products Offered
    • 12.3.5 Takeda Recent Development
  • 12.4 Pfizer
    • 12.4.1 Pfizer Corporation Information
    • 12.4.2 Pfizer Business Overview
    • 12.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Pfizer Biological Drugs Products Offered
    • 12.4.5 Pfizer Recent Development
  • 12.5 Amgen
    • 12.5.1 Amgen Corporation Information
    • 12.5.2 Amgen Business Overview
    • 12.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Amgen Biological Drugs Products Offered
    • 12.5.5 Amgen Recent Development
  • 12.6 F. Hoffmann-La Roche
    • 12.6.1 F. Hoffmann-La Roche Corporation Information
    • 12.6.2 F. Hoffmann-La Roche Business Overview
    • 12.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
    • 12.6.5 F. Hoffmann-La Roche Recent Development
  • 12.7 Johnson & Johnson
    • 12.7.1 Johnson & Johnson Corporation Information
    • 12.7.2 Johnson & Johnson Business Overview
    • 12.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Johnson & Johnson Biological Drugs Products Offered
    • 12.7.5 Johnson & Johnson Recent Development
  • 12.8 Merck
    • 12.8.1 Merck Corporation Information
    • 12.8.2 Merck Business Overview
    • 12.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Merck Biological Drugs Products Offered
    • 12.8.5 Merck Recent Development
  • 12.9 Abbott Laboratories
    • 12.9.1 Abbott Laboratories Corporation Information
    • 12.9.2 Abbott Laboratories Business Overview
    • 12.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Abbott Laboratories Biological Drugs Products Offered
    • 12.9.5 Abbott Laboratories Recent Development
  • 12.10 Baxter
    • 12.10.1 Baxter Corporation Information
    • 12.10.2 Baxter Business Overview
    • 12.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Baxter Biological Drugs Products Offered
    • 12.10.5 Baxter Recent Development
  • 12.11 Novartis
    • 12.11.1 Novartis Corporation Information
    • 12.11.2 Novartis Business Overview
    • 12.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Novartis Biological Drugs Products Offered
    • 12.11.5 Novartis Recent Development
  • 12.12 Biogen
    • 12.12.1 Biogen Corporation Information
    • 12.12.2 Biogen Business Overview
    • 12.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Biogen Biological Drugs Products Offered
    • 12.12.5 Biogen Recent Development
  • 12.13 GlaxoSmithKline
    • 12.13.1 GlaxoSmithKline Corporation Information
    • 12.13.2 GlaxoSmithKline Business Overview
    • 12.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 GlaxoSmithKline Biological Drugs Products Offered
    • 12.13.5 GlaxoSmithKline Recent Development

13 Biological Drugs Manufacturing Cost Analysis

  • 13.1 Biological Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Biological Drugs
  • 13.4 Biological Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Biological Drugs Distributors List
  • 14.3 Biological Drugs Customers

15 Market Dynamics

  • 15.1 Biological Drugs Market Trends
  • 15.2 Biological Drugs Drivers
  • 15.3 Biological Drugs Market Challenges
  • 15.4 Biological Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Biological Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Therapeutic Protein
    Monoclonal Antibody
    Vaccine
    Others

    Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others

    The Biological Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Biological Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Bristol-Myers Squibb
    Eli Lilly
    Takeda
    Pfizer
    Amgen
    F. Hoffmann-La Roche
    Johnson & Johnson
    Merck
    Abbott Laboratories
    Baxter
    Novartis
    Biogen
    GlaxoSmithKline

    Buy now